dr_alimuhammad's profile picture. Radiation Oncologist,Peter MacCallum Cancer Centre,interested in Head and neck/GU cancers. PhD candidate(SABR in RCC), husband/dad and proud arsenal Supporter

Muhammad Ali

@dr_alimuhammad

Radiation Oncologist,Peter MacCallum Cancer Centre,interested in Head and neck/GU cancers. PhD candidate(SABR in RCC), husband/dad and proud arsenal Supporter

Muhammad Ali reposted

Huge congratulations to Dr Muhammad Ali - winner of the Elekta Award at #RANZCR2025 for advances in the use of technology in #radiotherapy 🏆 Awarded for his Phase 2 RCT of Neoadj Pembro + #SABR before nephrectomy for #RCC (NAPSTER) @dr_alimuhammad @RANZCRcollege @PeterMacCC

PeterMacRadOnc's tweet image. Huge congratulations to Dr Muhammad Ali - winner of the Elekta Award at #RANZCR2025 for advances in the use of technology in #radiotherapy 🏆

Awarded for his Phase 2 RCT of Neoadj Pembro + #SABR before nephrectomy for #RCC (NAPSTER)

@dr_alimuhammad @RANZCRcollege @PeterMacCC
PeterMacRadOnc's tweet image. Huge congratulations to Dr Muhammad Ali - winner of the Elekta Award at #RANZCR2025 for advances in the use of technology in #radiotherapy 🏆

Awarded for his Phase 2 RCT of Neoadj Pembro + #SABR before nephrectomy for #RCC (NAPSTER)

@dr_alimuhammad @RANZCRcollege @PeterMacCC
PeterMacRadOnc's tweet image. Huge congratulations to Dr Muhammad Ali - winner of the Elekta Award at #RANZCR2025 for advances in the use of technology in #radiotherapy 🏆

Awarded for his Phase 2 RCT of Neoadj Pembro + #SABR before nephrectomy for #RCC (NAPSTER)

@dr_alimuhammad @RANZCRcollege @PeterMacCC

Should we think about 3 tier SABR response following kidney SABR? @_ShankarSiva @ChadTangMD @jryckman3 @NicholasZaorsky I am just liking this initial version which I just put together for a recent talk. May be adding “reassuring” for non-progressive

dr_alimuhammad's tweet image. Should we think about 3 tier SABR response following kidney SABR? @_ShankarSiva @ChadTangMD @jryckman3 @NicholasZaorsky 

I am just liking this initial version which I just put together for a recent talk. May be adding “reassuring” for non-progressive

Muhammad Ali reposted

5 weeks left to register for @PeterMacCC #SABR2025!   Expert discussions, interactive sessions, fantastic faculty @PeterMacRadOnc @PBlanchardMD @lauren_henke @BarbaraJereczek @DrewMoghanaki @Melissa_O_Neil This always sells out, register soon! sabrsymposium.com

_ShankarSiva's tweet image. 5 weeks left to register for @PeterMacCC #SABR2025!
 
Expert discussions, interactive sessions, fantastic faculty @PeterMacRadOnc 
@PBlanchardMD
@lauren_henke
@BarbaraJereczek
@DrewMoghanaki
@Melissa_O_Neil

This always sells out, register soon! sabrsymposium.com

Muhammad Ali reposted

Renal cell carcinoma squad at ASTRO 2025!

SimonLo21054188's tweet image. Renal cell carcinoma squad at ASTRO 2025!

Muhammad Ali reposted

🆕 @dr_alimuhammad NAPSTER trial (n=20): First-in-human neoadjuvant SABR ± pembrolizumab before nephrectomy in ccRCC ✅ All pts completed SABR ± IO; 18/20 underwent nephrectomy (all R0) 🩺 no grade 4–5 AEs; surgical complications minimal ⭐️Feasible & safe; immune analyses to…

_ShankarSiva's tweet image. 🆕 @dr_alimuhammad NAPSTER trial (n=20): First-in-human neoadjuvant SABR ± pembrolizumab before nephrectomy in ccRCC

✅ All pts completed SABR ± IO; 18/20 underwent nephrectomy (all R0)
🩺 no grade 4–5 AEs; surgical complications minimal

⭐️Feasible & safe; immune analyses to…
_ShankarSiva's tweet image. 🆕 @dr_alimuhammad NAPSTER trial (n=20): First-in-human neoadjuvant SABR ± pembrolizumab before nephrectomy in ccRCC

✅ All pts completed SABR ± IO; 18/20 underwent nephrectomy (all R0)
🩺 no grade 4–5 AEs; surgical complications minimal

⭐️Feasible & safe; immune analyses to…
_ShankarSiva's tweet image. 🆕 @dr_alimuhammad NAPSTER trial (n=20): First-in-human neoadjuvant SABR ± pembrolizumab before nephrectomy in ccRCC

✅ All pts completed SABR ± IO; 18/20 underwent nephrectomy (all R0)
🩺 no grade 4–5 AEs; surgical complications minimal

⭐️Feasible & safe; immune analyses to…
_ShankarSiva's tweet image. 🆕 @dr_alimuhammad NAPSTER trial (n=20): First-in-human neoadjuvant SABR ± pembrolizumab before nephrectomy in ccRCC

✅ All pts completed SABR ± IO; 18/20 underwent nephrectomy (all R0)
🩺 no grade 4–5 AEs; surgical complications minimal

⭐️Feasible & safe; immune analyses to…

On way to @ASTRO_org #ASTRO25. If you are attending, please join us on Monday 29/9 for session “Revelations in Renal radiotherapy” @_ShankarSiva @ChadTangMD

dr_alimuhammad's tweet image. On way to @ASTRO_org  #ASTRO25. If you are attending, please join us on Monday 29/9 for session “Revelations in Renal radiotherapy” @_ShankarSiva @ChadTangMD
dr_alimuhammad's tweet image. On way to @ASTRO_org  #ASTRO25. If you are attending, please join us on Monday 29/9 for session “Revelations in Renal radiotherapy” @_ShankarSiva @ChadTangMD
dr_alimuhammad's tweet image. On way to @ASTRO_org  #ASTRO25. If you are attending, please join us on Monday 29/9 for session “Revelations in Renal radiotherapy” @_ShankarSiva @ChadTangMD

Muhammad Ali reposted

Emerging PET tracers in RCC -—CA-IX, PSMA & sestamibi — high sensitivity/specificity for renal mass characterization & staging. Is this what the future holds in #kidneycancer ? Out now Weindler at al. @BMJ_Open bmjoncology.bmj.com/content/4/1/e0… #kcsm

_ShankarSiva's tweet image. Emerging PET tracers in RCC  -—CA-IX, PSMA & sestamibi — high sensitivity/specificity for renal mass characterization & staging. Is this what the future holds in #kidneycancer ? Out now Weindler at al.  @BMJ_Open bmjoncology.bmj.com/content/4/1/e0… #kcsm
_ShankarSiva's tweet image. Emerging PET tracers in RCC  -—CA-IX, PSMA & sestamibi — high sensitivity/specificity for renal mass characterization & staging. Is this what the future holds in #kidneycancer ? Out now Weindler at al.  @BMJ_Open bmjoncology.bmj.com/content/4/1/e0… #kcsm
_ShankarSiva's tweet image. Emerging PET tracers in RCC  -—CA-IX, PSMA & sestamibi — high sensitivity/specificity for renal mass characterization & staging. Is this what the future holds in #kidneycancer ? Out now Weindler at al.  @BMJ_Open bmjoncology.bmj.com/content/4/1/e0… #kcsm
_ShankarSiva's tweet image. Emerging PET tracers in RCC  -—CA-IX, PSMA & sestamibi — high sensitivity/specificity for renal mass characterization & staging. Is this what the future holds in #kidneycancer ? Out now Weindler at al.  @BMJ_Open bmjoncology.bmj.com/content/4/1/e0… #kcsm

Muhammad Ali reposted

Really excited to see this paper live on BMJ Oncology! The authors have provided a comprehensive overview of novel radiopharmaceuticals for molecular imaging of renal cell carcinoma🔬 bmjoncology.bmj.com/content/4/1/e0… @_ShankarSiva @BMJOncology #oncology #renalcellcarcinoma

PharmKristoffer's tweet image. Really excited to see this paper live on BMJ Oncology!  The authors have provided a comprehensive overview of novel radiopharmaceuticals for molecular imaging of renal cell carcinoma🔬  
bmjoncology.bmj.com/content/4/1/e0…
@_ShankarSiva @BMJOncology 
#oncology #renalcellcarcinoma

Muhammad Ali reposted

Please join our esteemed international RO speakers in Melbourne in October for #RANZCR2025! Early bird registrations close 15 July 2025. ranzcrasm.com @RANZCRcollege @NiuSanford @reshmajagsi @SahgalArjun @AmarUKishan @SimonLo21054188 @jmmrad @BoekeSimon @GkikaEleni2

weeloonong's tweet image. Please join our esteemed international RO speakers in Melbourne in October for #RANZCR2025! Early bird registrations close 15 July 2025.

ranzcrasm.com @RANZCRcollege 

@NiuSanford @reshmajagsi @SahgalArjun @AmarUKishan @SimonLo21054188 @jmmrad @BoekeSimon @GkikaEleni2
weeloonong's tweet image. Please join our esteemed international RO speakers in Melbourne in October for #RANZCR2025! Early bird registrations close 15 July 2025.

ranzcrasm.com @RANZCRcollege 

@NiuSanford @reshmajagsi @SahgalArjun @AmarUKishan @SimonLo21054188 @jmmrad @BoekeSimon @GkikaEleni2

As #RANZCR2024 comes to a close, it is my honour to be the RO convenor for #RANZCR2025, with a line-up of esteemed international speakers (more TBC). Please save the date, and see you in Melbourne 23-25 October 2025! @AmarUKishan @SahgalArjun @NiuSanford @fabiomoraesmd

weeloonong's tweet image. As #RANZCR2024 comes to a close, it is my honour to be the RO convenor for #RANZCR2025, with a line-up of esteemed international speakers (more TBC). Please save the date, and see you in Melbourne 23-25 October 2025!

@AmarUKishan @SahgalArjun @NiuSanford @fabiomoraesmd


Today, we achieved a small milestone of registering the 100th prospective patient at Peter MacCallum Cancer Centre. @_ShankarSiva @MellyB_7 @declangmurphy @PeterMacRadOnc @PeterMacCC irockregistry.com


Right atrial angiosarcoma not for surgery 5.5cm What should be the radiotherapy dose/fraction? @DrewMoghanaki @jryckman3 @_ShankarSiva


Muhammad Ali reposted

Is there a role for PSMA PET/CT in oligometatastic RCC? Check out our @JournalofNucMed PEDESTAL study on PSMA-guided metastasis-directed therapy from @PeterMacCC @_ShankarSiva @DrMHofman 🧍33 pts & 60 metastases 🛜 93% radiotherapy 📖Median follow-up> 4y ✅Local control: 94%…

cristian_udo's tweet image. Is there a role for PSMA PET/CT in oligometatastic RCC? 
Check out our @JournalofNucMed PEDESTAL study on PSMA-guided metastasis-directed therapy from @PeterMacCC @_ShankarSiva @DrMHofman 

🧍33 pts & 60 metastases
🛜 93% radiotherapy
📖Median follow-up> 4y

✅Local control: 94%…
cristian_udo's tweet image. Is there a role for PSMA PET/CT in oligometatastic RCC? 
Check out our @JournalofNucMed PEDESTAL study on PSMA-guided metastasis-directed therapy from @PeterMacCC @_ShankarSiva @DrMHofman 

🧍33 pts & 60 metastases
🛜 93% radiotherapy
📖Median follow-up> 4y

✅Local control: 94%…

United States Trends

Loading...

Something went wrong.


Something went wrong.